What is Pathology Arts?
Pathology Arts specializes in accurate clinical analysis, offering a comprehensive suite of services including IHC testing and special stain requests. The company serves a diverse clientele, encompassing outpatient surgery centers, higher education research institutions, and various medical specialties such as GYN, GU, GI, and Dermatopathology. Their commitment to quality patient care is underscored by their continuous exploration of new technologies to enhance their diagnostic offerings.
How much funding has Pathology Arts raised?
Pathology Arts has raised a total of $89K across 1 funding round:
Debt
$89K
Debt (2021): $89K with participation from PPP
Key Investors in Pathology Arts
PPP
Public-Private Partnership
What's next for Pathology Arts?
Operating at a significant Series B/C stage, Pathology Arts is poised for strategic advancement. The recent infusion of substantial expansion capital is expected to fuel further development of their service portfolio and technological capabilities. This investment will likely enable Pathology Arts to broaden its market reach across California and potentially beyond, reinforcing its position as a leading provider of anatomical pathology services and enhancing its capacity to support complex research and clinical diagnostics.
See full Pathology Arts company page
